Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/31/2008EP2009006A1 Ureide derivative and use thereof for medical purposes
12/31/2008EP2009004A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
12/31/2008EP2009000A1 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
12/31/2008EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP2008691A1 Vaginal odorants
12/31/2008EP2008663A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
12/31/2008EP2008662A1 Lypolysis promoter
12/31/2008EP2008660A1 Inhibitors of acetylcholinesterase for treating skin diseases
12/31/2008EP2008659A1 Liquid pharmaceutical formulations of palonosetron
12/31/2008EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008EP2008657A2 Use of rapamycin derivatives in vasculopathies
12/31/2008EP2008656A1 Compositions for the treatment of hyperphenylalaninemia
12/31/2008EP2008655A1 Pharmaceutical composition that comprises an analgesic and vitamins
12/31/2008EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides
12/31/2008EP2008653A1 Serotonergic compounds for treating neuronal illnesses
12/31/2008EP2008652A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/31/2008EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol
12/31/2008EP2008649A1 Spill resistant pharmaceutical compositions
12/31/2008EP2008532A1 Method for production of capsinoid-containing beverage/food
12/31/2008EP2008531A1 Composition for foods and drinks having improved hygroscopicity
12/31/2008EP2008274A2 Compositions and methods for inhibiting expression of eg5 gene
12/31/2008EP2008107A2 Detection of steroid receptors on circulating carcinoma cells and treatment
12/31/2008EP2007826A1 Gels
12/31/2008EP2007783A2 Novel aminoglycosides and uses thereof in the treatment of genetic disorders
12/31/2008EP2007777A1 Calixarene derivatives as anticancer agent
12/31/2008EP2007774A1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
12/31/2008EP2007773A1 Thiazolyl dihydro-indazoles
12/31/2008EP2007772A1 Thiazolyl-dihydroquinazolines
12/31/2008EP2007770A1 Imidazo compounds
12/31/2008EP2007769A1 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
12/31/2008EP2007767A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
12/31/2008EP2007765A2 Immunopotentiating compounds
12/31/2008EP2007759A1 Isoxazole derivatives as calcium channel blockers
12/31/2008EP2007758A1 A novel crystalline form of lamivudine
12/31/2008EP2007757A2 Thiophene-carboxamides useful as inhibitors of protein kinases
12/31/2008EP2007756A2 Modulators of atp-binding cassette transporters
12/31/2008EP2007755A2 Fused ring thrombin receptor antagonists
12/31/2008EP2007754A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
12/31/2008EP2007753A1 Heterocyclic gaba alpha subtype selective receptor modulators
12/31/2008EP2007752A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
12/31/2008EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
12/31/2008EP2007750A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
12/31/2008EP2007749A2 Tetralines antagonists of the h-3 receptor
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007746A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
12/31/2008EP2007741A1 Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
12/31/2008EP2007736A1 Substituted quinazolines with anti-cancer activity
12/31/2008EP2007735A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
12/31/2008EP2007733A1 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
12/31/2008EP2007732A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/31/2008EP2007731A2 Process for the preparation of caprolactam cgrp antagonist intermediate
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007725A2 Non-peptidic renin inhibitors nitroderivatives
12/31/2008EP2007724A1 Piperidine derivatives for treatment of alzheimer's disease
12/31/2008EP2007723A2 Organic compounds
12/31/2008EP2007722A1 Adamantane derivatives for the treatment of the metabolic syndrome
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP2007716A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
12/31/2008EP2007715A2 Tetracycline compounds and methods of treatment
12/31/2008EP2007714A2 Orally bioavailable caffeic acid related anticancer drugs
12/31/2008EP2007711A1 5-aminolevulinic acid salts and their use
12/31/2008EP2007709A2 Crystal forms of o-desmethylvenlafaxine
12/31/2008EP2007707A1 Compounds which modulate the cb2 receptor
12/31/2008EP2007702A2 Conjugated lipid derivatives
12/31/2008EP2007479A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
12/31/2008EP2007429A1 Oral formulation with beneficial cardiovascular effects, comprising berberine
12/31/2008EP2007408A2 Preventative treatment and remission of allergic diseases
12/31/2008EP2007401A2 Anti-inflammatory polymer
12/31/2008EP2007400A1 New medicines for treatments against retroviruses
12/31/2008EP2007397A2 Solid oral dosage form containing an enhancer
12/31/2008EP2007396A1 Antifungal agents
12/31/2008EP2007395A1 Cgrp antagonist salt
12/31/2008EP2007394A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses
12/31/2008EP2007393A2 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
12/31/2008EP2007391A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
12/31/2008EP2007389A2 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
12/31/2008EP2007388A2 Opiopathies
12/31/2008EP2007387A2 Dental appliance cleanser
12/31/2008EP2007386A2 Camptothecin-analog with a novel, flipped lactone-stable, e-ring and methods for making and using same
12/31/2008EP2007385A2 Cardiovascular composition and use the same for the treatment of alzheimers disease
12/31/2008EP2007384A1 Orodispersible domperidone tablets
12/31/2008EP2007383A2 Inhibitors of protein prenyltransferases
12/31/2008EP2007382A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
12/31/2008EP2007381A2 Compositions and methods of use of ritonavir for treating hcv
12/31/2008EP2007380A2 Use of a kinase inhibitor for the treatment of particular resistant tumors
12/31/2008EP2007378A1 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
12/31/2008EP2007377A2 Antibacterial agents
12/31/2008EP2007376A2 Therapeutic uses of cannabidiol compounds
12/31/2008EP2007374A2 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same
12/31/2008EP2007373A2 Inhibition of alpha-synuclein toxicity
12/31/2008EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof
12/31/2008EP2007370A1 Novel composition for tumor growth control
12/31/2008EP2007369A2 Use of rasagiline for the treatment of restless legs syndrome
12/31/2008EP2007368A2 Compositions and methods for enhancing the antioxidant status of animals
12/31/2008EP2007367A1 Medicated feed premix comprising chlortetracycline hydrochloride
12/31/2008EP2007366A2 Animal product enrichment using resveratrol
12/31/2008EP2007365A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
12/31/2008EP2007364A1 Transcription factor modulator
12/31/2008EP2007363A2 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
1 ... 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 ... 7860